Covering Coronavirus: Seattle, Washington (podcast) | FRONTLINE
Lessons learned from Seattle — an epicenter of the COVID-19 outbreak. Veteran science reporter and FRONTLINE correspondent Miles O’Brien takes us inside the state where coronavirus was first believed to hit U.S. soil, where he finds, “They’ve put science at the center of their policy, and they’ve let the data drive the decisions.”

This journalism is made possible by viewers like you. Support your local PBS station here: http://www.pbs.org/donate

Subscribe on YouTube: http://bit.ly/1BycsJW

#COVID-19 #Coronavirus #Podcast #Documentary #frontlinePBS

Instagram: https://www.instagram.com/frontlinepbs
Twitter: https://twitter.com/frontlinepbs
Facebook: https://www.facebook.com/frontline

FRONTLINE is streaming more than 200 documentaries online, for free, here: http://to.pbs.org/hxRvQP

The FRONTLINE Dispatch is produced at FRONTLINE’s headquarters at WGBH in Boston and distributed by PRX, a leading podcast creator and distributor working closely with WGBH on a range of podcast initiatives. The FRONTLINE Dispatch is made possible by a generous gift from the Abrams Foundation Journalism Initiative.

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.